Regulation of Mammary Cell Proliferation by Apical Polarity Proteins

Project: Research project

Description

DESCRIPTION (provided by applicant): Breast cancer is a leading cause of cancer death among women. Current strategies to combat breast cancer mainly target late stage malignancies to extend lifespan;consequently, they often fail to result in disease free survival. While detection of pre-malignant lesions is increasingly accurate, the inability to predict which precancerous lesions lead to neoplastic growth has impeded efforts to identify patients that are likely to develop aggressive neoplasms or drugs to prevent this. This study addresses this issue by defining how the early loss of cellular differentiation is coordinated with the induction of aberrant proliferation by the adaptor protein Amot. Because the breakdown of the apical polarity is one of the earliest essential steps for cells to be sensitized to pro-growth signaling, such studies may explain how highly proliferative breast cancer cells that utilize ErbB type receptor tyrosine kinases for growth are formed. Our model relating these effects to a cellular mechanism posits that polarity proteins induce the prolonged activation of MAPKs. This is consistent with several reports that Ras and Erk1/2 must be targeted to endosomes to undergo prolonged activation that is required for cellular proliferation. The implications of this model for promoting the formation and progression of ErbB2 and triple negative type breast cancers will be investigated. PUBLIC HEALTH RELEVANCE: A majority of the 40,000 mortalities from breast cancer each year follow therapeutic strategies that target late stage malignant tumors. The premise of this proposal is that long-term survival could be substantially improved if early hyperplastic lesions were prevented from developing into aggressive cancers;a process that is mainly characterized by the loss of epithelial architecture and aberrant cellular accumulation. To this end, this study will investigate a novel mechanism whereby loss of cellular shape directly regulates cell growth to promote early initiation of cellular proliferation and invasiveness.
StatusFinished
Effective start/end date7/1/114/30/16

Funding

  • National Institutes of Health: $312,953.00
  • National Institutes of Health: $302,972.00
  • National Institutes of Health: $293,799.00
  • National Institutes of Health: $312,755.00
  • National Institutes of Health: $312,126.00

Fingerprint

Breast
Cell Proliferation
Breast Neoplasms
Growth
Triple Negative Breast Neoplasms
Neoplasms
Proteins
Endosomes
Protein-Tyrosine Kinases
Disease-Free Survival
Cause of Death
Pharmaceutical Preparations
ErbB Receptors

ASJC

  • Medicine(all)